AlphaFold predicted structure
ITGB6 · P18564

Mean pLDDT
82.9/ 100
Confident
788 residues
Confidence breakdown
- Very high(≥ 90)39%
- Confident(70–90)45%
- Low(50–70)10%
- Very low(< 50)5%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
integrin subunit beta 6
Annotations refreshed 9 hours ago.
Diagnostic Grade (Green)
Amelogenesis imperfecta
BIALLELIC, autosomal or pseudoautosomalIntellectual disability
BIALLELIC, autosomal or pseudoautosomalamelogenesis imperfecta
Hypoplastic amelogenesis imperfecta
Alopecia-intellectual disability syndrome
smoking initiation
hypocalcified amelogenesis imperfecta
alopecia - intellectual disability syndrome
non-small cell lung carcinoma
membranous glomerulonephritis
adolescent idiopathic scoliosis
metabolic syndrome
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Integrin beta-6
Integrin alpha-V:beta-6 (ITGAV:ITGB6) is a receptor for fibronectin and cytotactin (PubMed:17158881, PubMed:17545607). It recognizes the sequence R-G-D in its ligands (PubMed:17158881, PubMed:17545607). Internalization of integrin alpha-V/beta-6 via clathrin-mediated endocytosis promotes carcinoma cell invasion (PubMed:17158881, PubMed:17545607). ITGAV:ITGB6 acts as a receptor for fibrillin-1 (FBN1) and mediates R-G-D-dependent cell adhesion to FBN1 (PubMed:17158881). Integrin alpha-V:beta-6 (ITGAV:ITGB6) mediates R-G-D-dependent release of transforming growth factor beta-1 (TGF-beta-1) from regulatory Latency-associated peptide (LAP), thereby playing a key role in TGF-beta-1 activation (PubMed:15184403, PubMed:22278742, PubMed:28117447)
Curated MONDO disease pages that list ITGB6 among their top associated genes.
ITGB6 · P18564

Mean pLDDT
82.9/ 100
Confident
788 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0